Glyburide
- Product NDC
- 0121-0930
- 11-digit product format
- 001210930
- Labeler code
- 0121
- Product ID
- 0121-0930_bb1c127b-43e9-1772-e053-2995a90a03ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Pharmaceutical Associates, Inc.
- Application
- ANDA206483
- Marketing category
- ANDA
- Marketing start
- 2021-01-01
- Marketing end
- 0000-00-00
- Substance
- GLYBURIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0121-0930-90 | 00121093090 | 100 TABLET in 1 BOTTLE (0121-0930-90) | 100 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |
| 0121-0930-91 | 00121093091 | 500 TABLET in 1 BOTTLE (0121-0930-91) | 500 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |